Vaccine Manufacturing
Sector | Healthcare & Pharma
Vaccination is a cornerstone of public health, yet Syria currently depends entirely on imported vaccines. This project proposes the establishment of a regional vaccine manufacturing facility to produce key pediatric and adult vaccines, aligned with WHO prequalification standards for humanitarian and regional supply.

Capital Requirement

$20–30 million

Breakeven

4-5 Years

Download Details

Dr. Haytham Albizem, MD, FACC, FACP
President – Strategic Investment Group
📧 admin@sig.international
📱 +1 (267) 252-6408
📍 Philadelphia, PA | Damascus, Syria